Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: Impact on cancer recurrence and survival

European Journal of Cardio-thoracic Surgery

Volumn 44, Issue 4, 2013, Pages

  Pirro, Matteo ^a   Cagini, Lucio ^a   Paciullo, Francesco ^a   Pecoriello, Roberta ^a   Mannarino, Massimo R ^a   Bagaglia, Francesco ^a   Capozzi, Rosanna ^a   Puma, Francesco ^a   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Endothelial progenitors; Non small cell lung cancer; Surgery; Survival

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADENOSQUAMOUS CARCINOMA; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOID; CELL LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; EVENT FREE SURVIVAL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MALE; MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; THORAX SURGERY; TRIACYLGLYCEROL BLOOD LEVEL;

ENDOTHELIAL PROGENITORS; NON-SMALL-CELL LUNG CANCER; SURGERY; SURVIVAL;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL CELLS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; PROSPECTIVE STUDIES; STEM CELLS;

EID: 84892923318     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt382     Document Type: Article

References (25)

1. Melero-Martin JM, Dudley AC. Concise review: vascular stem cells and tumor angiogenesis. Stem Cells 2011;29:163-8.
2. Purhonen S, Palm J, Rossi D, Kaskenpää N, Rajantie I, Ylä-Herttuala S et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA 2008;105:6620-5.
3. Yoder MC, Ingram DA. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol 2009;16:269-73.
4. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008;319:195-8.
5. Fadini GP, de Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 2008;28:997-1004.
6. Yue WS, Wang M, Yan GH, Yiu KH, Yin L, Lee SW et al. Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease. Am J Cardiol 2010;106:1248-54.
7. Pirro M, Schillaci G, Menecali C, Bagaglia F, Paltriccia R, Vaudo G et al. Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J Hypertens 2007;25:2093-9.
8. Pirro M, Schillaci G, Paltriccia R, Bagaglia F, Menecali C, Mannarino MR et al. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006;26:2530-5.
9. Pirro M, Schillaci G, Bagaglia F, Menecali C, Paltriccia R, Mannarino MR et al. Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis 2008;197:757-67.
10. Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006;66:7341-7.
11. Pircher A, Kähler CM, Skvortsov S, Dlaska M, Kawaguchi G, Schmid T et al. Increased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer: a methodological challenge and an ongoing debate on the clinical relevance. Oncol Rep 2008;19:345-52.
12. Nowak K, Rafat N, Belle S, Weiss C, Hanusch C, Hohenberger P et al. Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease. Eur J Cardiothorac Surg 2010; 37:758-63.
13. Morita R, Sato K, Nakano M, Miura H, Odaka H, Nobori K et al. Endothelial progenitor cells are associated with response to chemotherapy in human non-small-cell lung cancer. J Cancer Res Clin Oncol 2011; 137:1849-57.
14. Schillaci G, Rondelli F, Pirro M, Bagaglia F, Pucci G, Noya G et al. Endothelial progenitor cells are mobilized after major laparotomic surgery in patients with cancer. Int J Immunopathol Pharmacol 2009;22:1035-41.
15. Stein A, Montens HP, Steppich B, Busch G, Brandl R, Ott I. Circulating endothelial progenitor cells decrease in patients after endarterectomy. J Vasc Surg 2008;48:1217-22.
16. Cagini L, Capozzi R, Tassi V, Savignani C, Quintaliani G, Reboldi G et al. Fluid and electrolyte balance after major thoracic surgery by bioimpedance and endocrine evaluation. Eur J Cardiothorac Surg 2011;40:e71-76.
17. Sakamori Y, Masago K, Ohmori K, Togashi Y, Nagai H, Okuda C et al. Increase in circulating endothelial progenitor cells predicts response in patients with advanced non-small-cell lung cancer. Cancer Sci 2012;103:1065-70.
18. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 7th edn. Chicago, IL: Springer., 2010.
19. Pirro M, Bocci EB, Di Filippo F, Schillaci G, Mannarino MR, Bagaglia F et al. Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment. J Intern Med 2012;272:177-84.
20. Shaked Y, Henke E, Roodhart JM, Mancuso P, Langenberg MH, Colleoni M et al. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 2008;14:263-73.
21. Arias JI, Aller MA, Arias J. Cancer cell: using inflammation to invade the host. Mol Cancer 2007;6:29.
22. Roodhart JM, Langenberg MH, Vermaat JS, Lolkema MP, Baars A, Giles RH et al. Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients. Neoplasia 2010;12:87-94.
23. Laack E, Köhler A, Kugler C, Dierlamm T, Knuffmann C, Vohwinkel G et al. Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer. Ann Oncol 2002; 13:1550-7.
24. Condon ET, Wang JH, Redmond HP. Surgical injury induces the mobilization of endothelial progenitor cells. Surgery 2004;135:657-61.
25. Maeda R, Ishii G, Ito M, Hishida T, Yoshida J, Nishimura M et al. Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes. J Thorac Oncol 2012; 7:503-11.